These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 23649092

  • 1. Novel synthetic (poly)glycerolphosphate-based antistaphylococcal conjugate vaccine.
    Chen Q, Dintaman J, Lees A, Sen G, Schwartz D, Shirtliff ME, Park S, Lee JC, Mond JJ, Snapper CM.
    Infect Immun; 2013 Jul; 81(7):2554-61. PubMed ID: 23649092
    [Abstract] [Full Text] [Related]

  • 2. Monophosphoryl lipid A as a co-adjuvant in methicillin-resistant Staphylococcus aureus vaccine development: improvement of immune responses in a mouse model of infection.
    Mirshekar M, Haghighat S, Mousavi Z, Abdolghaffari AH, Yazdi MH.
    Immunol Res; 2024 Jun; 72(3):490-502. PubMed ID: 38383811
    [Abstract] [Full Text] [Related]

  • 3. Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal Poly-N-acetyl-beta-(1-6)-glucosamine.
    Maira-Litrán T, Kropec A, Goldmann DA, Pier GB.
    Infect Immun; 2005 Oct; 73(10):6752-62. PubMed ID: 16177353
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A.
    Maira-Litrán T, Bentancor LV, Bozkurt-Guzel C, O'Malley JM, Cywes-Bentley C, Pier GB.
    PLoS One; 2012 Oct; 7(9):e43813. PubMed ID: 22970144
    [Abstract] [Full Text] [Related]

  • 5. c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection.
    Hu DL, Narita K, Hyodo M, Hayakawa Y, Nakane A, Karaolis DK.
    Vaccine; 2009 Jul 30; 27(35):4867-73. PubMed ID: 19406185
    [Abstract] [Full Text] [Related]

  • 6. Immunization of aged mice with a pneumococcal conjugate vaccine combined with an unmethylated CpG-containing oligodeoxynucleotide restores defective immunoglobulin G antipolysaccharide responses and specific CD4+-T-cell priming to young adult levels.
    Sen G, Chen Q, Snapper CM.
    Infect Immun; 2006 Apr 30; 74(4):2177-86. PubMed ID: 16552048
    [Abstract] [Full Text] [Related]

  • 7. Synthetic teichoic acid conjugate vaccine against nosocomial Gram-positive bacteria.
    Laverde D, Wobser D, Romero-Saavedra F, Hogendorf W, van der Marel G, Berthold M, Kropec A, Codee J, Huebner J.
    PLoS One; 2014 Apr 30; 9(10):e110953. PubMed ID: 25333799
    [Abstract] [Full Text] [Related]

  • 8. A Single B-repeat of Staphylococcus epidermidis accumulation-associated protein induces protective immune responses in an experimental biomaterial-associated infection mouse model.
    Yan L, Zhang L, Ma H, Chiu D, Bryers JD.
    Clin Vaccine Immunol; 2014 Sep 30; 21(9):1206-14. PubMed ID: 24920603
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of phytol-derived diterpenoid immunoadjuvants over alum in shaping the murine host's immune response to Staphylococcus aureus.
    Roy Chowdhury R, Fitch RW, Ghosh SK.
    Vaccine; 2013 Feb 06; 31(8):1178-86. PubMed ID: 23313815
    [Abstract] [Full Text] [Related]

  • 10. One Dose of Staphylococcus aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4+ T Cells, and IL-17A.
    Mancini F, Monaci E, Lofano G, Torre A, Bacconi M, Tavarini S, Sammicheli C, Arcidiacono L, Galletti B, Laera D, Pallaoro M, Tuscano G, Fontana MR, Bensi G, Grandi G, Rossi-Paccani S, Nuti S, Rappuoli R, De Gregorio E, Bagnoli F, Soldaini E, Bertholet S.
    PLoS One; 2016 Feb 06; 11(1):e0147767. PubMed ID: 26812180
    [Abstract] [Full Text] [Related]

  • 11. Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.
    Li X, Wang X, Thompson CD, Park S, Park WB, Lee JC.
    mBio; 2016 Feb 02; 7(1):e02232-15. PubMed ID: 26838725
    [Abstract] [Full Text] [Related]

  • 12. A β-mannan trisaccharide conjugate vaccine aids clearance of Candida albicans in immunocompromised rabbits.
    Lipinski T, Wu X, Sadowska J, Kreiter E, Yasui Y, Cheriaparambil S, Rennie R, Bundle DR.
    Vaccine; 2012 Sep 28; 30(44):6263-9. PubMed ID: 22902677
    [Abstract] [Full Text] [Related]

  • 13. Immunisation With Immunodominant Linear B Cell Epitopes Vaccine of Manganese Transport Protein C Confers Protection against Staphylococcus aureus Infection.
    Yang HJ, Zhang JY, Wei C, Yang LY, Zuo QF, Zhuang Y, Feng YJ, Srinivas S, Zeng H, Zou QM.
    PLoS One; 2016 Sep 28; 11(2):e0149638. PubMed ID: 26895191
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of serotypes 5 and 8 capsular polysaccharides in protection against Staphylococcus aureus in murine models of infection.
    Cheng BL, Nielsen TB, Pantapalangkoor P, Zhao F, Lee JC, Montgomery CP, Luna B, Spellberg B, Daum RS.
    Hum Vaccin Immunother; 2017 Jul 03; 13(7):1609-1614. PubMed ID: 28422567
    [Abstract] [Full Text] [Related]

  • 15. CNA-loaded PLGA nanoparticles improve humoral response againstS. aureus-mediated infections in a mouse model: subcutaneous vs. nasal administration strategy.
    Genta I, Colonna C, Conti B, Caliceti P, Salmaso S, Speziale P, Pietrocola G, Chiesa E, Modena T, Dorati R.
    J Microencapsul; 2016 Dec 03; 33(8):750-762. PubMed ID: 27845595
    [Abstract] [Full Text] [Related]

  • 16. Protective efficacy of a novel alpha hemolysin subunit vaccine (AT62) against Staphylococcus aureus skin and soft tissue infections.
    Adhikari RP, Thompson CD, Aman MJ, Lee JC.
    Vaccine; 2016 Dec 07; 34(50):6402-6407. PubMed ID: 27847174
    [Abstract] [Full Text] [Related]

  • 17. Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: Phase III randomized study.
    Fattom A, Matalon A, Buerkert J, Taylor K, Damaso S, Boutriau D.
    Hum Vaccin Immunother; 2015 Dec 07; 11(3):632-41. PubMed ID: 25483694
    [Abstract] [Full Text] [Related]

  • 18. Antibodies to Staphylococcus aureus serotype 8 capsular polysaccharide react with and protect against serotype 5 and 8 isolates.
    Park S, Gerber S, Lee JC.
    Infect Immun; 2014 Dec 07; 82(12):5049-55. PubMed ID: 25245803
    [Abstract] [Full Text] [Related]

  • 19. NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults.
    Schmidt CS, White CJ, Ibrahim AS, Filler SG, Fu Y, Yeaman MR, Edwards JE, Hennessey JP.
    Vaccine; 2012 Dec 14; 30(52):7594-600. PubMed ID: 23099329
    [Abstract] [Full Text] [Related]

  • 20. Recombinant ESAT-6-like proteins provoke protective immune responses against invasive Staphylococcus aureus disease in a murine model.
    Zhang BZ, Hua YH, Yu B, Lau CC, Cai JP, Zheng SY, Yam WC, Kao RY, Sze KH, Zheng BJ, Yuen KY, Huang JD.
    Infect Immun; 2015 Jan 14; 83(1):339-45. PubMed ID: 25368117
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.